EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021

Ninell Kadyrova, Dzintars Gotham iD, Stanislav Kniazkov iD, Elsever Aghayev, Polad Hajibalayev, Zohid Ermatov, Natasha Azzopardi Muscat

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0294680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Ninell Kadyrova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pricing and Reimbursement Analytics Team, Regional Office for Europe, World Health Organization, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Asthma, Cardiovascular Diseases, Drugs, Essential, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, World Health Organization Regional Office for Europe, Azerbaijan State Advanced Training Institute for Doctors.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Access to medicines is a global priority. Azerbaijan, Georgia, and Uzbekistan have different approaches to pricing policies for pharmaceuticals. The aim of this study was to analyze recent trends in the consumption and prices of non-communicable disease (NCD) medicines in Azerbaijan, Georgia, and Uzbekistan, in the outpatient setting.

Methods

We included medicines for asthma and COPD, cancer, cardiovascular disease, diabetes, epilepsy, and mental disorders. Sales data for pharmaceutical products in community pharmacies were extracted from a commercial database. Changes in consumption and prices were analyzed across all included NCD medicines, by disease category and pharmacological group.

Results

Consumption of NCD medicines was highest in Georgia, at twice the levels in Azerbaijan, and four times levels in Uzbekistan. Average prices of NCD medicines, weighted by consumption, increased by 26% in Georgia, but decreased by 3% in Azerbaijan and by 0.1% in Uzbekistan. Prices increased for all disease groups in Georgia (from +13% for epilepsy medicines to +86% for cancer), varied by group in Uzbekistan (from -22% for epilepsy medicines to +47% for cancer), while changes in Azerbaijan were smaller in magnitude (from -4% for medicines for cardiovascular disease to +11% for cancer). Cancer medicines had markedly higher prices in Uzbekistan, and asthma and COPD medicines had markedly higher prices in Azerbaijan and Uzbekistan.

Conclusions

Georgia showed the highest outpatient consumption of NCD medicines, suggesting the broadest access to treatment. However, Georgia also saw marked price increases, greater than in the other countries. In Georgia, where there was no price regulation, widespread price increases and increases in consumption both contribute to increasing pharmaceutical expenditures. In Azerbaijan and Uzbekistan, increases in outpatient pharmaceutical expenditures were primarily driven by increases in consumption, rather than increases in price. Comparing trends in consumption and pricing can identify gaps in access and inform future policy approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaCardiovascular DiseasesDrugs, EssentialEpilepsyNeoplasmsNoncommunicable DiseasesPulmonary Disease, Chronic ObstructiveHumansAzerbaijanUzbekistanGeorgia (Republic)

Substanzen

Drugs, Essential

Autor:innen und Institutionen

  • Pricing and Reimbursement Analytics Team, Regional Office for Europe, World Health Organization, Copenhagen, Denmark.
  • Pharmacological and Pharmacopoeial Expert Council, Ministry of Health of the Republic of Azerbaijan, Baku, Azerbaijan.
  • Pharmaceutical Faculty, Azerbaijan State Advanced Training Institute for Doctors named after A. Aliyev, Baku, Azerbaijan.
  • State Medical Insurance Fund, Tashkent, Uzbekistan.
  • Health Policies and Systems, Regional Office for Europe, World Health Organization, Copenhagen, Denmark.

ORCID-Profile: Dzintars Gotham, Stanislav Kniazkov

Förderung

  • World Health Organization
  • World Health Organization Regional Office for Europe
  • Azerbaijan State Advanced Training Institute for Doctors

Zitieren

APA

Kadyrova, N., Gotham, D., Kniazkov, S., Aghayev, E., Hajibalayev, P., Ermatov, Z., & Azzopardi Muscat, N. (2023). Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021. PLOS ONE. https://doi.org/10.1371/journal.pone.0294680

Vancouver

Kadyrova N, Gotham D, Kniazkov S, Aghayev E, Hajibalayev P, Ermatov Z, et al. Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021. PLOS ONE. 2023. doi:10.1371/journal.pone.0294680

BibTeX
@article{Kadyrova2023,
  author = {Kadyrova, Ninell and Gotham, Dzintars and Kniazkov, Stanislav and Aghayev, Elsever and Hajibalayev, Polad and Ermatov, Zohid and Azzopardi Muscat, Natasha},
  title = {Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0294680}
}
Kostenlos starten →